Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel.
Clinical cancer research : an official journal of the American Association for Cancer Research 09, 2020 | Pubmed ID: 32669372